Related Experiment Video
Updated: Dec 3, 2025

05:16
Author Spotlight: Utilization of Decellularized Spleen Matrix for Bioartificial Livers
Published on: February 9, 2024
978
Decellularized Splenic Matrix as a Scaffold for Spleen Bioengineering
Tadeu Ériton Caliman Zanardo1,2, Fernanda Gobbi Amorim1,3, Gabriel Henrique Taufner1,2
1Biotechnology Graduate Program, Rede Nordeste de Biotecnologia (RENORBIO), Vitória, Brazil.
Frontiers in Bioengineering and Biotechnology
|October 30, 2020
Summary
Researchers developed a decellularized splenic scaffold for potential spleen bioengineering and transplantation. This innovative approach aims to restore splenic function and reduce risks associated with spleen removal or dysfunction.
Area of Science:
- Regenerative Medicine
- Tissue Engineering
- Immunology
Background:
- The spleen is vital for immune function, and its absence or dysfunction leads to increased susceptibility to infections, thromboembolism, and cancer.
- Current spleen-preserving surgical techniques have limitations, with high morbidity and mortality rates persisting.
- Developing functional bioengineered spleens is crucial for addressing these clinical challenges.
Purpose of the Study:
- To create a viable splenic scaffold using decellularization for recellularization and potential transplantation.
- To evaluate the structural integrity and biocompatibility of the decellularized splenic matrix.
- To assess the potential of the scaffold for supporting cell adhesion, proliferation, and viability for spleen reconstruction.
Main Methods:
- Decellularization technique applied to spleen tissue to create a biological scaffold.
- Assessment of structural components (white pulp, red pulp, vascular network) and matrix preservation.
- Evaluation of residual DNA and SDS to minimize immunogenicity.
- Partial recellularization of the scaffold with neonatal rat spleen stromal cells.
Main Results:
- The decellularized scaffold preserved key splenic structural components and vascular networks.
- Minimal residual DNA and SDS were detected, crucial for reducing immune rejection.
- Approximately 72% of matrisomal protein content was retained, indicating matrix integrity.
- Recellularization demonstrated successful cell adhesion, proliferation, and viability on the scaffold.
Conclusions:
- The developed splenic scaffold is a promising foundation for spleen reconstruction and bioengineered spleen transplantation.
- This approach holds potential for complete recovery of splenic function in future clinical applications.
- Further research into complete recellularization and functional assessment is warranted.

